MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
8.36
-0.01
-0.12%
After Hours: 8.31 -0.05 -0.59% 19:57 09/11 EDT
OPEN
8.40
PREV CLOSE
8.37
HIGH
8.52
LOW
8.07
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
18.31
52 WEEK LOW
8.07
MARKET CAP
676.33M
P/E (TTM)
-6.5574
1D
5D
1M
3M
1Y
5Y
1D
Phathom Pharmaceuticals: Specialist Economics Strengthens The Bull Case
Seeking Alpha · 2d ago
Phathom Pharmaceuticals Price Target Announced at $10.00/Share by Leerink Partners
Dow Jones · 2d ago
Leerink Partners Initiates Coverage On Phathom Pharmaceuticals with Market Perform Rating, Announces Price Target of $10
Benzinga · 2d ago
Leerink starts Phathom Pharmaceuticals at Market Perform on limited upside
TipRanks · 2d ago
Phathom Pharmaceuticals initiated with a Market Perform at Leerink
TipRanks · 2d ago
Weekly Report: what happened at PHAT last week (0831-0904)?
Weekly Report · 4d ago
Weekly Report: what happened at PHAT last week (0824-0828)?
Weekly Report · 08/31 09:45
Weekly Report: what happened at PHAT last week (0817-0821)?
Weekly Report · 08/24 09:46
More
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the commercialization and development of novel treatments for gastrointestinal diseases. It has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) for the United States (U.S.), Europe and Canada. PCABs are a novel class of molecules that block acid secretion in the stomach. The Company markets vonoprazan in the U.S. as VOQUEZNA (vonoprazan) tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (Non-Erosive GERD) in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of VOQUEZNA DUAL PAK (vonoprazan tablets, amoxicillin capsules) and VOQUEZNA TRIPLE PAK (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) for the treatment of H. pylori infection in adults.

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.